-+ 0.00%
-+ 0.00%
-+ 0.00%

Exploring 3 Undervalued Small Caps With Insider Action In Global Markets

Simply Wall St·08/18/2026 09:09:28
Listen to the news

In recent weeks, global markets have experienced mixed performances, with easing inflation concerns and favorable AI-related earnings news providing some optimism, while rising oil prices and geopolitical uncertainties continue to weigh on investor sentiment. The Russell 2000 Index has shown resilience, outperforming major benchmarks with a notable year-to-date gain of over 23%, highlighting the potential opportunities within the small-cap sector amidst these dynamic market conditions. In this environment, identifying stocks that are potentially undervalued can be particularly appealing to investors seeking growth opportunities. Small-cap companies with insider activity may offer unique insights into their potential value and performance in the global markets.

Top 10 Undervalued Small Caps With Insider Buying Globally

Name PE PS Discount to Fair Value Value Rating
Nederman Holding 18.6x 0.8x 26.02% ★★★★★☆
NoHo Partners Oyj 15.9x 0.5x 31.49% ★★★★☆☆
Linc 13.0x 13.5x 30.05% ★★★★☆☆
Sagicor Financial 7.1x 0.5x -84.02% ★★★★☆☆
Natural Food International Holding 11.5x 1.2x 7.87% ★★★☆☆☆
CellaVision 28.0x 4.9x 42.44% ★★★☆☆☆
Yellow Pages 7.9x 0.8x 31.93% ★★★☆☆☆
Pizza Pizza Royalty 13.9x 10.7x 29.76% ★★★☆☆☆
Travis Perkins NA 0.3x -76.92% ★★★☆☆☆
Hong Fok 22.9x 6.6x 29.57% ★★★☆☆☆

Click here to see the full list of 132 stocks from our Undervalued Global Small Caps With Insider Buying screener.

Here we highlight a subset of our preferred stocks from the screener.

Cogstate (ASX:CGS)

Simply Wall St Value Rating: ★★★★★☆

Overview: Cogstate is a company specializing in cognitive science and technology, focusing on healthcare and clinical trials, with a market cap of A$0.23 billion.

Operations: Cogstate's revenue primarily comes from its Clinical Trials segment, which significantly outpaces the Healthcare segment. The company has experienced fluctuations in its gross profit margin, with a notable increase to 60.53% by June 2025. Operating expenses have been consistently high, predominantly driven by general and administrative costs. Despite these expenses, net income margin showed improvement over time, reaching 19.22% by December 2025.

PE: 30.6x

Cogstate, a smaller player in its field, has shown promising growth with annual revenue climbing to US$60.86 million from US$53.09 million last year. Despite relying on higher-risk external borrowing for funding, the company boasts high-quality earnings and forecasts a 23% annual earnings growth. Recent insider confidence is evident through share purchases over the past few months, reflecting belief in Cogstate's potential as it expands clinical trial contracts and enhances average contract value through strategic solutions like central rating services.

ASX:CGS Share price vs Value as at Aug 2026
ASX:CGS Share price vs Value as at Aug 2026

BTB Real Estate Investment Trust (TSX:BTB.UN)

Simply Wall St Value Rating: ★★★★☆☆

Overview: BTB Real Estate Investment Trust is a Canadian company focused on owning and managing a diversified portfolio of industrial, suburban office, and necessity-based retail properties, with a market capitalization of CA$0.29 billion.

Operations: BTB Real Estate Investment Trust generates revenue primarily from its industrial, suburban office, and necessity-based retail segments. Over recent periods, the gross profit margin has shown a notable trend with figures such as 58.68% and 57.18%. Operating expenses have been consistently recorded around CA$9 million in recent times.

PE: 13.5x

BTB Real Estate Investment Trust is focusing on strategic portfolio shifts, recently selling two office properties for C$20 million to enhance its industrial holdings. Despite a dip in revenue over the past five years, recent earnings show improvement with net income rising to C$8.77 million for Q2 2026 from C$6.19 million a year ago. Insider confidence is evident as they increase their stakes, signaling belief in future growth potential amid ongoing executive changes aimed at optimizing operations and strategy execution.

TSX:BTB.UN Share price vs Value as at Aug 2026
TSX:BTB.UN Share price vs Value as at Aug 2026

Journey Energy (TSX:JOY)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Journey Energy is a Canadian oil and gas company focused on the exploration, development, and production of crude oil and natural gas in Western Canada, with a market capitalization of approximately CA$0.28 billion.

Operations: Journey Energy generates revenue primarily through its sales, with a recent quarterly revenue of CA$180.25 million and a gross profit margin of 51.52%. The company faces costs such as cost of goods sold (COGS) and operating expenses, which include depreciation and amortization (D&A) expenses. Net income has shown variability, with the latest net income at CA$26.79 million, reflecting a net income margin of 14.86%.

PE: 14.7x

Journey Energy, a smaller company in the energy sector, showcases potential for growth with earnings projected to rise nearly 29% annually. Recent financials reveal a second-quarter revenue increase to C$55.38 million from C$42.63 million last year, while net income surged to C$18.51 million from C$4.07 million. Despite relying solely on external borrowing for funding, insider confidence is evident through recent share purchases by executives this year, hinting at belief in future prospects amidst stable operational guidance for 2026.

TSX:JOY Ownership Breakdown as at Aug 2026
TSX:JOY Ownership Breakdown as at Aug 2026

Where To Now?

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.